Indefinite Delivery Contract 36C24223D0073

This Indefinite Delivery Contract (IDC) was awarded by the Veterans Integrated Service Network 2 (VISN 2), a component of the U.S. Department of Veterans Affairs (VA), to Cardinal Health 414, LLC, a subsidiary of the global healthcare company Cardinal Health, Inc. The contract has a ceiling value of $1,300,000.00 and covers the supply of nuclear medicine radiopharmaceuticals, including specialized medical isotopes such as technetium-99m, iodine-123, iodine-131, indium-111, thallium-201, fluorine-18 FDG, and gallium-67, as well as radiopharmaceutical therapies like Xofigo (radium-223 dichloride) for prostate cancer treatment. These products support nuclear medicine, oncology, and diagnostic imaging services at VA medical centers, military treatment facilities, and National Institutes of Health (NIH) research centers nationwide.

The contract is structured as a single-award IDC with a period of performance from July 1, 2023, to June 30, 2026. It includes three delivery order task orders, valued at $325,000.00 each, for the supply of these critical radiopharmaceutical products to VA facilities in New York and Ohio. Cardinal Health 414, LLC has extensive experience in handling and distributing time-sensitive, radioactive medical products, and holds multiple IDC contracts with various VISN networks within the VA, demonstrating the company's critical role in supporting the federal healthcare system's nuclear medicine and diagnostic imaging capabilities.